Central Line-Associated Bloodstream Infection (CLABSI)

A new AHA Trailblazers report, “Small Things Matter in Infection Prevention,” explores how hospitals are expanding surveillance programs to include peripheral intravenous catheters (PIVCs) and other vascular access devices — an area that represents both high volume and untapped opportunity for…
A study published by JAMA Aug. 13 found that a two-dose antibiotic treatment could be just as effective as traditional long-term IV therapy for treating serious Staphylococcus aureus bloodstream infections.
The Centers for Disease Control and Prevention Nov. 6 released its annual progress report on health care-associated infections, which showed continued decreases in hospitalizations last year.
A Case Study in Reducing Central Line-Associated Bloodstream Infection (CLABSI) Rates The Overlooked Patient and Economic Burden of Blood Culture ContaminationWednesday, February 7, 2024   1 - 2 p.m. Eastern; noon - 1 p.m. Central; 10 - 11 a.m. Pacific  
Reducing blood culture contamination is critical for accurate diagnosis and effective treatment of bloodstream infections. To achieve sustained reduction in blood culture contamination, a multifaceted approach — incorporating technique, technology, and process improvement —has proven to be…
Henry Ford’s hematology-oncology unit has reduced the incidence of CLABSIs in its hematology-oncology unit by 75%, documenting only two cases between July 2020 and June 2021.
In this episode of the Advancing Health podcast series, Nishant Prasad, M.D., attending physician and program director of infectious diseases at NewYork-Presbyterian Queens, shares how they re-approached CLABSI prevention by deeply examining structure and process, and how their work got them to…
The customizable toolkit offers resources to help prevent central line-associated bloodstream infections and catheter-associated urinary tract infections.